• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agilent Technologies prepares for IPO

Article

Newly spun-off Hewlett-Packard healthcare operation Agilent Technologies has filed a registration statement with the Securities and Exchange Commission for a proposed public offering, the company has announced. Agilent will offer 57 million shares of

Newly spun-off Hewlett-Packard healthcare operation Agilent Technologies has filed a registration statement with the Securities and Exchange Commission for a proposed public offering, the company has announced. Agilent will offer 57 million shares of common stock, 45.6 million offered in the U.S. and Canada, and 11.4 million of which will be offered internationally. Estimated IPO price per share is between $19 and $22, according to Agilent. Morgan Stanley Dean Witter and Goldman, Sachs & Company are handling the offering.

In March, Palo Alto, CA-based Hewlett-Packard spun off its medical products group, along with four other businesses, in an effort to focus on its computer business (SCAN 3/17/99). The name Agilent Technologies was chosen for the $8 billion Andover, MA, company in August (SCAN 8/4/99).

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.